MCH ADVISORY RESEARCH
Theme

Digital Payments & Fintech

Payment rails, exchanges, brokerage and consumer finance.

37 covered names · ranked by upside
Equity Research

Block, Inc (XYZ)

HOLD. 12-month probability-weighted target $79 (-2% vs spot). Gross Margin explains 61% of Monte Carlo outcome variance.

XYZEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Wex Inc (WEX)

SELL. 12-month probability-weighted target $157 (-23% vs spot). P/E Multiple explains 77% of Monte Carlo outcome variance.

WEXEquity ResearchMonte Carlo
25 August 2026Rating: SELL
Equity Research

Visa Inc. Class A (V)

HOLD. 12-month probability-weighted target $339 (-11% vs spot). P/E Multiple explains 94% of Monte Carlo outcome variance.

VEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Synchrony Financial (SYF)

HOLD. 12-month probability-weighted target $75 (-6% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

SYFEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

S&P Global Inc (SPGI)

HOLD. 12-month probability-weighted target $397 (-9% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

SPGIEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

SLM Corp (SLM)

HOLD. 12-month probability-weighted target $25 (-4% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

SLMEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Stifel Financial Corporation (SF)

HOLD. 12-month probability-weighted target $79 (-3% vs spot). P/E Multiple explains 90% of Monte Carlo outcome variance.

SFEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Charles Schwab Corp (SCHW)

SELL. 12-month probability-weighted target $91 (-20% vs spot). P/E Multiple explains 91% of Monte Carlo outcome variance.

SCHWEquity ResearchMonte Carlo
25 August 2026Rating: SELL
Equity Research

Raymond James Financial Inc. (RJF)

SELL. 12-month probability-weighted target $154 (-13% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

RJFEquity ResearchMonte Carlo
25 August 2026Rating: SELL
Equity Research

PayPal Holdings Inc (PYPL)

SELL. 12-month probability-weighted target $45 (-28% vs spot). P/E Multiple explains 55% of Monte Carlo outcome variance.

PYPLEquity ResearchMonte Carlo
25 August 2026Rating: SELL
Equity Research

Nasdaq Inc (NDAQ)

SELL. 12-month probability-weighted target $82 (-17% vs spot). P/E Multiple explains 95% of Monte Carlo outcome variance.

NDAQEquity ResearchMonte Carlo
25 August 2026Rating: SELL
Equity Research

MSCI Inc (MSCI)

HOLD. 12-month probability-weighted target $550 (-4% vs spot). P/E Multiple explains 89% of Monte Carlo outcome variance.

MSCIEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Morgan Stanley (MS)

HOLD. 12-month probability-weighted target $202 (-6% vs spot). P/E Multiple explains 78% of Monte Carlo outcome variance.

MSEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Morningstar Inc (MORN)

SELL. 12-month probability-weighted target $169 (-22% vs spot). P/E Multiple explains 62% of Monte Carlo outcome variance.

MORNEquity ResearchMonte Carlo
25 August 2026Rating: SELL
Equity Research

Moodys Corporation (MCO)

HOLD. 12-month probability-weighted target $457 (-11% vs spot). P/E Multiple explains 86% of Monte Carlo outcome variance.

MCOEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Mastercard Inc (MA)

SELL. 12-month probability-weighted target $499 (-17% vs spot). P/E Multiple explains 94% of Monte Carlo outcome variance.

MAEquity ResearchMonte Carlo
25 August 2026Rating: SELL
Equity Research

Jack Henry & Associates Inc (JKHY)

SELL. 12-month probability-weighted target $132 (-23% vs spot). P/E Multiple explains 70% of Monte Carlo outcome variance.

JKHYEquity ResearchMonte Carlo
25 August 2026Rating: SELL
Equity Research

Intercontinental Exchange Inc (ICE)

SELL. 12-month probability-weighted target $123 (-25% vs spot). P/E Multiple explains 95% of Monte Carlo outcome variance.

ICEEquity ResearchMonte Carlo
25 August 2026Rating: SELL
Equity Research

Interactive Brokers Group Inc (IBKR)

HOLD. 12-month probability-weighted target $86 (-8% vs spot). P/E Multiple explains 91% of Monte Carlo outcome variance.

IBKREquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Robinhood Markets (HOOD)

SELL. 12-month probability-weighted target $79 (-24% vs spot). P/E Multiple explains 84% of Monte Carlo outcome variance.

HOODEquity ResearchMonte Carlo
25 August 2026Rating: SELL
Equity Research

Houlihan Lokey Inc (HLI)

HOLD. 12-month probability-weighted target $142 (+10% vs spot). P/E Multiple explains 90% of Monte Carlo outcome variance.

HLIEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Goldman Sachs Group Inc (GS)

HOLD. 12-month probability-weighted target $1005 (-3% vs spot). P/E Multiple explains 74% of Monte Carlo outcome variance.

GSEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Global Payments Inc (GPN)

SELL. 12-month probability-weighted target $70 (-26% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

GPNEquity ResearchMonte Carlo
25 August 2026Rating: SELL
Equity Research

Shift4 Payments Inc (FOUR)

HOLD. 12-month probability-weighted target $51 (+6% vs spot). P/E Multiple explains 49% of Monte Carlo outcome variance.

FOUREquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Fidelity National Information Services Inc (FIS)

HOLD. 12-month probability-weighted target $38 (-8% vs spot). P/E Multiple explains 80% of Monte Carlo outcome variance.

FISEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

FactSet Research Systems Inc (FDS)

SELL. 12-month probability-weighted target $236 (-23% vs spot). P/E Multiple explains 82% of Monte Carlo outcome variance.

FDSEquity ResearchMonte Carlo
25 August 2026Rating: SELL
Equity Research

FirstCash Inc (FCFS)

SELL. 12-month probability-weighted target $206 (-13% vs spot). Gross Margin explains 48% of Monte Carlo outcome variance.

FCFSEquity ResearchMonte Carlo
25 August 2026Rating: SELL
Equity Research

Evercore Partners Inc (EVR)

HOLD. 12-month probability-weighted target $333 (+15% vs spot). P/E Multiple explains 89% of Monte Carlo outcome variance.

EVREquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Euronet Worldwide Inc (EEFT)

BUY. 12-month probability-weighted target $87 (+24% vs spot). Gross Margin explains 60% of Monte Carlo outcome variance.

EEFTEquity ResearchMonte Carlo
25 August 2026Rating: BUY
Equity Research

Corpay Inc (CPAY)

SELL. 12-month probability-weighted target $344 (-17% vs spot). P/E Multiple explains 85% of Monte Carlo outcome variance.

CPAYEquity ResearchMonte Carlo
25 August 2026Rating: SELL
Equity Research

Coinbase Global Inc (COIN)

SELL. 12-month probability-weighted target $117 (-35% vs spot). Gross Margin explains 56% of Monte Carlo outcome variance.

COINEquity ResearchMonte Carlo
25 August 2026Rating: SELL
Equity Research

Capital One Financial Corporation (COF)

HOLD. 12-month probability-weighted target $196 (-9% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

COFEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

CME Group Inc (CME)

SELL. 12-month probability-weighted target $217 (-22% vs spot). P/E Multiple explains 95% of Monte Carlo outcome variance.

CMEEquity ResearchMonte Carlo
25 August 2026Rating: SELL
Equity Research

Cboe Global Markets Inc (CBOE)

SELL. 12-month probability-weighted target $235 (-24% vs spot). P/E Multiple explains 81% of Monte Carlo outcome variance.

CBOEEquity ResearchMonte Carlo
25 August 2026Rating: SELL
Equity Research

American Express Company (AXP)

HOLD. 12-month probability-weighted target $348 (+3% vs spot). P/E Multiple explains 64% of Monte Carlo outcome variance.

AXPEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Ally Financial Inc (ALLY)

HOLD. 12-month probability-weighted target $44 (+3% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

ALLYEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Sector Research

Robinhood Markets: Investment Research

An institutional-grade research report on Robinhood Markets (NASDAQ: HOOD), evaluating the company's competitive positioning, growth strategy, and investment thesis.

RobinhoodHOODFintechBrokerage
17 March 2026Sector Research
MCH ADVISORY SERVICES · All research · Not investment advicemchadvisoryservices.com ↗ · Research Standard v4 (decision-level) · Research OS ros-1.19.0 · US-listed · UK English